Skip to main content
. 2020 Dec 31;13(1):52. doi: 10.3390/v13010052

Figure 6.

Figure 6

Sangivamycin inhibits EBOV up to 24 h after addition relative to virus exposure. Huh7 cells were infected with EBOV and sangivamycin (A) or remdesivir (B) were added to the cells at 1, 2, 4, 8 and 24 h after virus exposure. Results are reported as percent inhibition and cytotoxicity relative to untreated controls. Each concentration was run in triplicate.